Stock Events

Stock Events

Qiagen NV 

€45.40
95
+€1.40+3.18%Wednesday 16:32

Statistics

Day High
45.4
Day Low
45
52W High
47.5
52W Low
28.4
Volume
2
Avg. Volume
391
Mkt Cap
9.37B
P/E Ratio
-
Dividend Yield
0.67%
Dividend
0.31

Upcoming

Dividends

0.67%Dividend Yield
Jul 2026
€0.31
Jan 2026
€2.07
Jul 2025
€0.22
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
36.25%

Earnings

Feb 9Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.46
0.5
0.54
0.58
Expected EPS
0.58222714032
Actual EPS
N/A

Financials

20.87%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.81BRevenue
378.12MNet Income

Analyst Ratings

$36.55Average Price Target
The highest estimate is ⁦41.73⁩.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QGE4.VI. It's not an investment recommendation.
AMD
16
AMD
Microsoft
15
MSFT
Alphabet
14
GOOGL
Apple
13
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Qiagen's sample and assay technologies.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers a broad range of reagents, instruments, and consumables used in biological and medical research, competing with Qiagen in multiple areas including sample preparation and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories offers products and systems used to separate complex chemical and biological materials, directly competing with Qiagen in the life sciences research market.
Agilent Technologies
A
Mkt Cap49.3B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, focusing on the life sciences, diagnostics, and applied chemical markets, competing with Qiagen in diagnostics and research.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers sequencing systems that compete with Qiagen's genomic and DNA sequencing solutions.
Repligen
RGEN
Mkt Cap11.23B
Repligen Corporation provides bioprocessing technologies and systems that compete with Qiagen's solutions for the purification and isolation of biological samples and substances.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, competes in the same space as its Class A shares, offering similar products and technologies that rival Qiagen's offerings.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics provides diagnostic testing, information, and services, competing with Qiagen in the diagnostics and molecular diagnostics markets.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with Qiagen in the precision medicine and cancer diagnostics space.

About

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between life sciences and molecular diagnostics applications. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
Show More
CEO
Jon Pratt
Employees
5500
Country
Netherlands
ISIN
NL0015002SN0
WKN
000A41HBE

Listings

F
DE
QIA.F
STU
DE
QIA.STU
MU
DE
QIA.MU
XNYS
US
QGEN

0 Comments

Share your thoughts

FAQs

What is Qiagen NV stock price today?▼
The current price of QGE4.VI is €45.40 EUR — it has increased by +3.18% in the past 24 hours. Watch Qiagen NV stock price performance more closely on the chart.
What is Qiagen NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Vienna Exchange exchange Qiagen NV stocks are traded under the ticker QGE4.VI.
What is Qiagen NV market cap?▼
Today Qiagen NV has the market capitalization of 9.37B
When is the next Qiagen NV earnings date?▼
Qiagen NV is going to release the next earnings report on February 9, 2027.
What were Qiagen NV earnings last quarter?▼
QGE4.VI earnings for the last quarter are 0.58 EUR per share, whereas the estimation was 0.56 EUR resulting in a +3.75% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Qiagen NV revenue for the last year?▼
Qiagen NV revenue for the last year amounts to 1.81B EUR.
What is Qiagen NV net income for the last year?▼
QGE4.VI net income for the last year is 378.12M EUR.
Does Qiagen NV pay dividends?▼
Yes, QGE4.VI dividends are paid annual. The last dividend per share was 0.31 . As of today, Dividend Yield (FWD)% is 0.67%.
How many employees does Qiagen NV have?▼
As of November 5, 2026, the company has 5,500 employees.
In which sector is Qiagen NV located?▼
Qiagen NV operates in the Health & Wellness sector.
When did Qiagen NV complete a stock split?▼
The last stock split for Qiagen NV was on January 8, 2026 with a ratio of 19:20.
Where is Qiagen NV headquartered?▼
Qiagen NV is headquartered in Venlo, Netherlands.